Fragment-Based Drug Discovery and X-Ray Crystallography

Thomas G. Davies (Curatore)

Marko Hyvönen (Curatore)

Springer-Verlag Berlin and Heidelberg GmbH & Co. KG, 2014

Introduction to Fragment-Based Drug Discovery, by Daniel A. Erlanson Fragment Screening Using X-Ray Crystallography, by Thomas G. Davies and Ian J. Tickle Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening, by Stephen Roughley, Lisa Wright, Paul Brough, Andrew Massey and Roderick E. Hubbard Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors, by Daniel F. Wyss, Yu-Sen Wang, Hugh L. Eaton, Corey Strickland, Johannes H. Voigt, Zhaoning Zhu and Andrew W. Stamford Combining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery, by Michael Hennig, Armin Ruf and Walter Huber Targeting Protein–Protein Interactions and Fragment-Based Drug Discovery, by Eugene Valkov, Tim Sharpe, May Marsh, Sandra Greive and Marko Hyvönen Fragment Screening and HIV Therapeutics, by Joseph D. Bauman, Disha Patel and Eddy Arnold Fragment-Based Approaches and Computer-Aided Drug Discovery, by Didier Rognan

• Curatore: Thomas G. Davies, Marko Hyvönen
• Editore: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
• Collana: Topics in Current Chemistry
• Anno: 2014
• Rilegatura: Paperback / softback
• Pagine: 228 p.
• Dimensioni: 235 x 155 mm
• EAN: 9783642446351

Testo in English